Pricing Log in Create free account

CNS Pharmaceuticals, Inc. (CNSP) vs Evogene Ltd. (EVGN)

CNS Pharmaceuticals, Inc. and Evogene Ltd. are both Biotechnology companies. CNS Pharmaceuticals, Inc. and Evogene Ltd. are of similar size ($6.0M and $5.9M). CNS Pharmaceuticals, Inc. has the higher net margin (0.00% vs −547.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, CNS Pharmaceuticals, Inc. leads on 8 and Evogene Ltd. on 4.

Valuation

Metric CNSP EVGN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.06 9.40
P/B 1.46 0.59 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.55 0.66
EV/Sales n/m (3.58) 9.02
Earnings yield (606.43%) (325.00%) (32.88%)
Free cash flow yield (50.55%) (315.60%) (23.13%)

Profitability

Metric CNSP EVGN Biotechnology median
Gross margin 0.00% (67.59%) 68.51%
Operating margin 0.00% (851.42%) 0.00%
Net margin 0.00% (547.62%) 0.00%
Free cash flow margin 0.00% (650.63%) 0.00%
Return on equity (106.62%) (100.03%) (51.96%)
Return on assets (91.64%) (38.31%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNSP EVGN Biotechnology median
Revenue growth (TTM) — (73.63%) 6.76%
EPS growth (last fiscal year) 92.34% 62.63% 29.88%
Revenue growth, 5-year CAGR — 29.94% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNSP EVGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.86 3.57 4.97
Net debt to EBITDA 0.45 1.12 1.01

Dividend

Metric CNSP EVGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNSP EVGN Biotechnology median
Market cap 5.86m 5.95m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack